Position in JANX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$1,294,701
New position
Shares Held
93,144
first reported quarter
Ownership
0.153%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Biotechnology
Healthcare · as of Mar 31, 2026Weiss Asset Management LP holds $310,556,482 across 19 Biotechnology names. JANX ranks #11 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TBPH |
Theravance Biopharma, Inc.
|
7,457,060 | $121,028,083 | |
| 2 | FOLD |
AMICUS THERAPEUTICS, INC.
|
3,872,902 | $56,002,162 | |
| 3 | MLTX |
MoonLake Immunotherapeutics
|
1,708,328 | $31,843,233 | |
| 4 | APLS |
Apellis Pharmaceuticals, Inc.
|
700,000 | $28,161,000 | |
| 5 | ALMS |
Alumis Inc.
|
1,097,417 | $24,176,096 | |
| 6 | CNTA |
Centessa Pharmaceuticals plc
|
510,407 | $20,273,366 | |
| 7 | COGT |
Cogent Biosciences, Inc.
|
346,104 | $13,321,542 | |
| 8 | MRNA |
Moderna, Inc.
|
93,720 | $4,760,976 |
All Filings in JANX
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,294,701 | 93,144 | Shares | Defined | 2026-05-15 | |
| No filing history on record for this holder in this stock. | ||||||